Potter M E, Moradi M, To A C, Hatch K D, Shingleton H M
Department of Obstetrics and Gynecology, University of Alabama, Birmingham 35294.
Gynecol Oncol. 1989 May;33(2):201-3. doi: 10.1016/0090-8258(89)90552-0.
Forty-five women with known histories of ovarian cancer underwent reoperative surgery. Thirty-seven patients underwent routine second-look laparotomy and eight patients were reexplored with clinical evidence of disease with the intent of re-resection. Preoperative CA 125 levels were obtained. Evaluation as to the predictive value of the CA 125 level and operative findings show a positive predictive value of 100% and a negative predictive value of 54%. Twenty of the forty-five patients had gross disease present on reoperation. Twenty patients were found to have persistent disease at reoperation. Twenty-five percent of patients with CA 125 levels less than or equal to 35 U/ml and 37% of these with CA 125 levels greater than 35 U/ml were resectable to no gross disease at the completion of the reoperation. CA 125 levels greater than or less than 35 U/ml were not predictive of the potential for re-resectability of the tumor.
45名有卵巢癌病史的女性接受了再次手术。37例患者接受了常规的二次剖腹探查术,8例患者因有疾病的临床证据而接受再次探查,目的是再次切除。术前测定了CA 125水平。对CA 125水平的预测价值和手术结果的评估显示,阳性预测值为100%,阴性预测值为54%。45例患者中有20例再次手术时存在肉眼可见的疾病。20例患者在再次手术时被发现有持续性疾病。CA 125水平小于或等于35 U/ml的患者中有25%,CA 125水平大于35 U/ml的患者中有37%在再次手术结束时可切除至无肉眼可见疾病。CA 125水平大于或小于35 U/ml并不能预测肿瘤再次切除的可能性。